Revolutionary Gene Therapy by Regeneron Enhances Hearing in Deaf Children

In a groundbreaking advancement in pediatric healthcare, Regeneron Pharmaceuticals has unveiled promising results from a recent gene therapy study that has shown significant improvement in hearing for children facing profound deafness. This innovative treatment aims to tackle genetic causes of hearing loss, providing hope to families struggling with this condition.

Continue reading